Remove Aneurysm Remove Hemorrhage Remove Inpatient
article thumbnail

Abstract TMP73: Incidence and Outcomes for Aneurysmal Subarachnoid Hemorrhage During Pregnancy: A 20-year Analysis of the National Inpatient Sample From 2000-2019

Stroke Journal

Introduction:Pregnancy is a risk factor for subarachnoid hemorrhage (SAH). We aim to better understand this risk and its impact on in-hospital outcomes over a longitudinal time period in a large population based sample.Methods:We analyzed the 2000-2019 National Inpatient Sample, selecting for aneurysmal SAH (aSAH).

article thumbnail

Abstract TP34: Outcomes and Trends of Subarachnoid Hemorrhage During the COVID-19 Pandemic

Stroke Journal

Our study aims to describe the trends and outcomes of patients with Subarachnoid Hemorrhage (SAH) using a Nationwide Inpatient Sample (NIS) database.Methods:We examined the 2016-2020 NIS database, focusing on patients aged 18 years and older with a primary SAH discharge diagnosis. years with 72,650 (61.0%) being female. to COVID 5.6 (p=0.0006).

article thumbnail

Abstract 113: Treatment of Tiny (? 3mm) Unruptured Middle Cerebral Artery Aneurysms Are Associated With High Risk of Procedural Complications: An Analysis of the Neurovascular Quality Initiative-Quality Outcomes Database

Stroke Journal

Introduction:Improved imaging modalities have led to an increased detection of intracranial aneurysms, many of which are small. Tiny size was defined as an aneurysm with a maximum dimension of ≤3 mm. Demographics, aneurysm characteristics and treatment safety were queried. The mean aneurysm width was 1.9

article thumbnail

Abstract TP19: Predictors of Outcome in Subarachnoid Hemorrhage in the Pediatric Population

Stroke Journal

Background:Studies describing outcomes of subarachnoid hemorrhage (SAH) in children are sparse. 320 patients (24.4%) were treated endovascularly and 480 (36.6%) were treated via open surgical approach to treat vascular pathologies (AV malformations, dural AV fistulas, and aneurysms). Median length of hospitalization was 9.7

article thumbnail

Abstract 005: Outcomes of Heparin Induced Thrombocytopenia Type II in Aneurysmal Subarachnoid Hemorrhage Patients

Stroke: Vascular and Interventional Neurology

Both anticoagulants can be used intraoperatively and postoperatively for DVT prophylaxis in patients undergoing subarachnoid hemorrhage (SAH) treatment. This nationwide, multicenter, retrospective study provides valuable insights for clinicians on how to prevent and manage HIT in patients with subarachnoid hemorrhage.

article thumbnail

Abstract 075: Treatment Trends and Clinical Outcomes of Endovascular Therapy for Pediatric Unruptured Intracranial Aneurysms

Stroke: Vascular and Interventional Neurology

IntroductionDue to the relative rarity of unruptured intracranial aneurysms (UIA) in the pediatric population, evidence regarding treatment modalities and clinical outcomes remains limited. days, p < 0.001), and lower rates of ischemic or hemorrhagic procedural‐related complications (1% vs. 4%, p = 0.010).ConclusionA

article thumbnail

Abstract 022: Acute Kidney Injury in Subarachnoid Hemorrhage: Exploring its Clinical Significance and Prognostic Implications

Stroke: Vascular and Interventional Neurology

IntroductionSubarachnoid Hemorrhage (SAH) resulting from the spontaneous rupture of an aneurysm is a rare and highly debilitating condition. Despite its severity, patients with aneurysmal SAH remain understudied, particularly concerning the evaluation of the incidence and consequences of subsequent acute kidney injury (AKI).